Literature DB >> 29948561

Managing PBC: Expanding the Provider Comfort Zone.

David M Chascsa1, Keith D Lindor2,3.   

Abstract

Year:  2018        PMID： 29948561     DOI： 10.1007/s10620-018-5162-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  6 in total

1.  Primary biliary cirrhosis.

Authors:  Keith D Lindor; M Eric Gershwin; Raoul Poupon; Marshall Kaplan; Nora V Bergasa; E Jenny Heathcote
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

2.  Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid.

Authors:  Albert Parés; Llorenç Caballería; Juan Rodés
Journal:  Gastroenterology       Date:  2006-03       Impact factor: 22.682

3.  Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.

Authors:  Christophe Corpechot; Ludovico Abenavoli; Nabila Rabahi; Yves Chrétien; Tony Andréani; Catherine Johanet; Olivier Chazouillères; Raoul Poupon
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

4.  Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness.

Authors:  Laura Jopson; Amardeep Khanna; Patricia Peterson; Elaine Rudell; Margaret Corrigan; David Jones
Journal:  Dig Dis Sci       Date:  2018-05-08       Impact factor: 3.199

5.  A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.

Authors:  Frederik Nevens; Pietro Andreone; Giuseppe Mazzella; Simone I Strasser; Christopher Bowlus; Pietro Invernizzi; Joost P H Drenth; Paul J Pockros; Jaroslaw Regula; Ulrich Beuers; Michael Trauner; David E Jones; Annarosa Floreani; Simon Hohenester; Velimir Luketic; Mitchell Shiffman; Karel J van Erpecum; Victor Vargas; Catherine Vincent; Gideon M Hirschfield; Hemant Shah; Bettina Hansen; Keith D Lindor; Hanns-Ulrich Marschall; Kris V Kowdley; Roya Hooshmand-Rad; Tonya Marmon; Shawn Sheeron; Richard Pencek; Leigh MacConell; Mark Pruzanski; David Shapiro
Journal:  N Engl J Med       Date:  2016-08-18       Impact factor: 91.245

6.  Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid.

Authors:  Gideon M Hirschfield; Andrew Mason; Velimir Luketic; Keith Lindor; Stuart C Gordon; Marlyn Mayo; Kris V Kowdley; Catherine Vincent; Henry C Bodhenheimer; Albert Parés; Michael Trauner; Hanns-Ulrich Marschall; Luciano Adorini; Cathi Sciacca; Tessa Beecher-Jones; Erin Castelloe; Olaf Böhm; David Shapiro
Journal:  Gastroenterology       Date:  2014-12-11       Impact factor: 22.682
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.